Flora Growth (FLGC) Projected to Post Quarterly Earnings on Wednesday

Flora Growth (NASDAQ:FLGC) will likely be releasing its Q3 2025 results before the market opens on Wednesday, November 12th. Analysts expect the company to announce earnings of ($2.13) per share for the quarter. Investors may visit the the company’s upcoming Q3 2025 earningresults page for the latest details on the call scheduled for Thursday, November 13, 2025 at 9:00 AM ET.

Flora Growth Stock Performance

NASDAQ FLGC opened at $9.38 on Wednesday. The business’s 50 day moving average price is $19.66 and its 200-day moving average price is $22.65. The company has a market cap of $6.68 million, a P/E ratio of -0.27 and a beta of 1.88. The company has a debt-to-equity ratio of 0.50, a quick ratio of 0.61 and a current ratio of 0.96. Flora Growth has a fifty-two week low of $8.73 and a fifty-two week high of $81.90.

Institutional Inflows and Outflows

A hedge fund recently raised its stake in Flora Growth stock. Geode Capital Management LLC lifted its position in Flora Growth Corp. (NASDAQ:FLGC) by 1.8% in the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 168,572 shares of the company’s stock after purchasing an additional 3,015 shares during the quarter. Geode Capital Management LLC owned about 29.16% of Flora Growth worth $98,000 as of its most recent SEC filing. Institutional investors own 36.01% of the company’s stock.

Wall Street Analysts Forecast Growth

Several equities analysts have commented on the company. Roth Capital set a $30.00 price objective on Flora Growth and gave the company a “buy” rating in a research report on Tuesday, August 5th. Weiss Ratings reissued a “sell (e+)” rating on shares of Flora Growth in a research report on Wednesday, October 8th. Finally, Wall Street Zen raised Flora Growth to a “hold” rating in a research report on Friday, September 26th. Two analysts have rated the stock with a Buy rating and one has issued a Sell rating to the company. According to MarketBeat.com, Flora Growth has an average rating of “Hold” and an average target price of $93.00.

About Flora Growth

Flora Growth Corp., together with its subsidiaries, engages in the growth, cultivation, and development of medicinal cannabis and medicinal cannabis derivative products worldwide. It operates through three segments: House of Brands, Commercial and Wholesale, and Pharmaceuticals. The company cultivates, processes, and supplies medicinal-grade cannabis flower, and cannabis derived medical and wellness products.